Riskpilot← Back to searchSign inGet full accessMEDICUS OCULUS AS
ASActiveOrg 993024414Marienbergveien 15, 7020 TrondheimMedical specialists activities · NACE 8622Est. 20082 employees
Revenue 2024
NOK 12,7M
+2% vs 2023
EBITDA margin
47.4%
+1% vs 2023
Equity ratio
20.3%
Financial strength
Net profit 2024
NOK 4,7M
+1% vs 2023
| Revenue | NOK 12,7M | +2% |
| EBITDA | NOK 6M | +1% |
| Net profit | NOK 4,7M | +1% |
| Total assets | NOK 8,1M | +5% |
| Equity | NOK 1,6M | +17% |
| Employees | 2 | — |
Legal name
MEDICUS OCULUS AS
Org number
993024414
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
28. august 2008
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av helsetjenester samt deltagelse i selskaper av samme eller annen art gjennom aksjetegning eller på annen måte.
Address
Marienbergveien 15, 7020 Trondheim
Phone
+4748206858
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 990 | 11 453 | 11 693 | 12 454 | 12 725 |
| Staff expenses | −2 021 | −2 076 | −2 063 | −2 138 | −2 175 |
| EBITDA | 4 219 | 5 271 | 5 205 | 6 005 | 6 038 |
| Depreciation & amort. | −67 | −66 | −74 | −61 | −63 |
| EBIT | 4 152 | 5 205 | 5 131 | 5 945 | 5 975 |
| Net financials | 20 | 7 | 13 | 50 | 108 |
| Profit before tax | 4 172 | 5 212 | 5 144 | 5 995 | 6 083 |
| Tax | 918 | 1 147 | 1 134 | 1 318 | 1 351 |
| Net profit | 3 254 | 4 066 | 4 010 | 4 677 | 4 731 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 740 | 5 770 | 6 837 | 7 685 | 8 060 |
| Equity | 200 | 1 215 | 1 225 | 1 402 | 1 633 |
| Long-term debt | 23 | 38 | 43 | 46 | 46 |
| Short-term debt | 6 517 | 4 517 | 5 569 | 6 238 | 6 381 |
| Total debt | 6 540 | 4 555 | 5 612 | 6 284 | 6 427 |
EBITDA margin
47.4%
This company
15.8%
Market median
+200% vs market
20202024
Equity ratio
20.3%
This company
38.2%
Market median
-47% vs market
20202024
Return on equity
289.7%
This company
18.4%
Market median
+1474% vs market
20202024
Net profit margin
37.2%
This company
8.1%
Market median
+359% vs market
20202024
Asset turnover
1.58×
This company
1.12×
Market median
+41% vs market
20202024
Debt / equity
3.93×
This company
0.62×
Market median
-534% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LE Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDICUS OCULUS AS 
NIDAROS ØYEKLINIKK ASBoard members of MEDICUS OCULUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linn Elisabeth Johnsen Knudtzon | Chief Executive Officer | 0 companies |
| Lars Ingvald Johnsen | Chairman | 0 companies |